101 related articles for article (PubMed ID: 27543882)
1. Studies on the inhibition of sphingosine-1-phosphate lyase by stabilized reaction intermediates and stereodefined azido phosphates.
Sanllehí P; Abad JL; Bujons J; Casas J; Delgado A
Eur J Med Chem; 2016 Nov; 123():905-915. PubMed ID: 27543882
[TBL] [Abstract][Full Text] [Related]
2. Bacterial versus human sphingosine-1-phosphate lyase (S1PL) in the design of potential S1PL inhibitors.
Sanllehí P; Abad JL; Casas J; Bujons J; Delgado A
Bioorg Med Chem; 2016 Sep; 24(18):4381-4389. PubMed ID: 27475537
[TBL] [Abstract][Full Text] [Related]
3. A Mechanism-Based Sphingosine-1-phosphate Lyase Inhibitor.
Pons G; Riba D; Casasampere M; Izquierdo E; Abad JL; Fabriàs G; Rodríguez Ortega PG; López-González JJ; Montejo M; Casas J; Delgado A
J Org Chem; 2020 Jan; 85(2):419-429. PubMed ID: 31860798
[TBL] [Abstract][Full Text] [Related]
4. Inhibitors of sphingosine-1-phosphate metabolism (sphingosine kinases and sphingosine-1-phosphate lyase).
Sanllehí P; Abad JL; Casas J; Delgado A
Chem Phys Lipids; 2016 May; 197():69-81. PubMed ID: 26200919
[TBL] [Abstract][Full Text] [Related]
5. A systematic methodology for large scale compound screening: A case study on the discovery of novel S1PL inhibitors.
Deniz U; Ozkirimli E; Ulgen KO
J Mol Graph Model; 2016 Jan; 63():110-24. PubMed ID: 26724452
[TBL] [Abstract][Full Text] [Related]
6. Hit-to-lead evaluation of a novel class of sphingosine 1-phosphate lyase inhibitors.
Dinges J; Harris CM; Wallace GA; Argiriadi MA; Queeney KL; Perron DC; Dominguez E; Kebede T; Desino KE; Patel H; Vasudevan A
Bioorg Med Chem Lett; 2016 May; 26(9):2297-302. PubMed ID: 27020302
[TBL] [Abstract][Full Text] [Related]
7. Sphingosine-1-phosphate metabolism: A structural perspective.
Pulkoski-Gross MJ; Donaldson JC; Obeid LM
Crit Rev Biochem Mol Biol; 2015; 50(4):298-313. PubMed ID: 25923252
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and evaluation of tetrahedral intermediate mimic inhibitors of 3-deoxy-d-manno-octulosonate 8-phosphate synthase.
Harrison AN; Reichau S; Parker EJ
Bioorg Med Chem Lett; 2012 Jan; 22(2):907-11. PubMed ID: 22204912
[TBL] [Abstract][Full Text] [Related]
9. Orally active 7-substituted (4-benzylphthalazin-1-yl)-2-methylpiperazin-1-yl]nicotinonitriles as active-site inhibitors of sphingosine 1-phosphate lyase for the treatment of multiple sclerosis.
Weiler S; Braendlin N; Beerli C; Bergsdorf C; Schubart A; Srinivas H; Oberhauser B; Billich A
J Med Chem; 2014 Jun; 57(12):5074-84. PubMed ID: 24809814
[TBL] [Abstract][Full Text] [Related]
10. Active-site engineering of benzaldehyde lyase shows that a point mutation can confer both new reactivity and susceptibility to mechanism-based inhibition.
Brandt GS; Kneen MM; Petsko GA; Ringe D; McLeish MJ
J Am Chem Soc; 2010 Jan; 132(2):438-9. PubMed ID: 20030408
[TBL] [Abstract][Full Text] [Related]
11. Structure and function of sphingosine-1-phosphate lyase, a key enzyme of sphingolipid metabolism.
Bourquin F; Riezman H; Capitani G; Grütter MG
Structure; 2010 Aug; 18(8):1054-65. PubMed ID: 20696404
[TBL] [Abstract][Full Text] [Related]
12. Inhibition mode of a bisubstrate inhibitor of KDO8P synthase: a frequency-selective REDOR solid-state and solution NMR characterization.
Kaustov L; Kababya S; Belakhov V; Baasov T; Shoham Y; Schmidt A
J Am Chem Soc; 2003 Apr; 125(15):4662-9. PubMed ID: 12683839
[TBL] [Abstract][Full Text] [Related]
13. A high-throughput scintillation proximity assay for sphingosine-1-phosphate lyase.
Kashem MA; Wa C; Wolak JP; Grafos NS; Ryan KR; Sanville-Ross ML; Fogarty KE; Rybina IV; Shoultz A; Molinaro T; Desai SN; Rajan A; Huber JD; Nelson RM
Assay Drug Dev Technol; 2014 Jun; 12(5):293-302. PubMed ID: 24846303
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and antibacterial activity of mechanism-based inhibitors of KDO8P synthase and DAH7P synthase.
Grison C; Petek S; Finance C; Coutrot P
Carbohydr Res; 2005 Mar; 340(4):529-37. PubMed ID: 15721322
[TBL] [Abstract][Full Text] [Related]
15. Determination of sphingosine-1-phosphate lyase activity by gas chromatography coupled to electron impact mass spectrometry.
Reina E; Camacho L; Casas J; Van Veldhoven PP; Fabrias G
Chem Phys Lipids; 2012 Feb; 165(2):225-31. PubMed ID: 22265672
[TBL] [Abstract][Full Text] [Related]
16. Assay to measure the secretion of sphingosine-1-phosphate from cells induced by S1P lyase inhibitors.
Loetscher E; Schneider K; Beerli C; Billich A
Biochem Biophys Res Commun; 2013 Apr; 433(3):345-8. PubMed ID: 23499842
[TBL] [Abstract][Full Text] [Related]
17. Structure-guided minimalist redesign of the L-fuculose-1-phosphate aldolase active site: expedient synthesis of novel polyhydroxylated pyrrolizidines and their inhibitory properties against glycosidases and intestinal disaccharidases.
Garrabou X; Gómez L; Joglar J; Gil S; Parella T; Bujons J; Clapés P
Chemistry; 2010 Sep; 16(35):10691-706. PubMed ID: 20661960
[TBL] [Abstract][Full Text] [Related]
18. Three-dimensional structures of enzyme-substrate complexes of the hydroxynitrile lyase from Hevea brasiliensis.
Zuegg J; Gruber K; Gugganig M; Wagner UG; Kratky C
Protein Sci; 1999 Oct; 8(10):1990-2000. PubMed ID: 10548044
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and evaluation of a mechanism-based inhibitor of a 3-deoxy-D-arabino heptulosonate 7-phosphate synthase.
Walker SR; Parker EJ
Bioorg Med Chem Lett; 2006 Jun; 16(11):2951-4. PubMed ID: 16563755
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of bis-Phosphate Iminoaltritol Enantiomers and Structural Characterization with Adenine Phosphoribosyltransferase.
Harris LD; Harijan RK; Ducati RG; Evans GB; Hirsch BM; Schramm VL
ACS Chem Biol; 2018 Jan; 13(1):152-160. PubMed ID: 29178779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
